ArticleTherapeutic advances in medical oncology2025

A cost-effectiveness comparison between immunotherapy combination regimens and sunitinib for advanced renal cell carcinoma in the USA and China.

Haojie Ying et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.